Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
HZ.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.69NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.98NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FL.8NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.71NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
HT.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.90NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FB.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FL.18.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FL.26NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EG.8NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FL.32NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FL.26.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EG.6NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FK.1.3.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FK.1.2.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.9NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GE.1.2.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
JN.1.58.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
JN.1.8.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
KP.1.1.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
JN.1.4.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XDD.1.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XDNNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
LT.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
JN.1.8.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
LV.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
JN.1.54.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
JN.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
JN.1.30.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
KP.1.1.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
MN.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
JN.1.63NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
LE.1.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
LH.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
HW.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
JN.1.55.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
JN.1.18.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XDK.4.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
KP.3.4.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
KP.2.11NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
LS.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.1.1 (Omicron)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.2.14NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.4 (Omicron)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.4.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.2.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.2.20NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used